GHK-Cu / KPV is a dual-compound research formulation combining the copper-binding peptide GHK-Cu with KPV, a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Both compounds have been studied independently in laboratory research involving cellular signaling, inflammatory pathways, tissue response, and mechanisms associated with cellular maintenance.

GHK-Cu research has explored its ability to bind copper ions and its relationship with biological processes involving extracellular matrix activity, collagen-related signaling, cellular migration, and tissue remodeling. Researchers have also investigated GHK-Cu in models examining oxidative stress, gene expression, and cellular responses associated with tissue integrity.

KPV research has focused primarily on inflammatory and immune-related signaling. Laboratory studies have examined its interactions with pathways associated with cytokine activity, epithelial response, and mucosal biology, including research models involving gastrointestinal and dermal tissues.

Combining 50mg GHK-Cu and 10mg KPV provides a multi-component formulation for controlled laboratory investigation of copper-peptide biology, inflammatory signaling, cellular response, and related biochemical pathways. This formulation is supplied in a nasal research format.